From a recent Cochrane review, the available moderate- to high-quality evidence from randomised controlled trials showed significant benefit from treating Bell’s palsy with corticosteroids. Only 1 in 10 patients treated with corticosteroids will not recover fully (95% CI 6 to 20).
Bell’s Palsy
Bell’s Palsy
Bell’s palsy (BP) is an idiopathic paralysis of the facial nerve and is the most common cause of lower motor neuron facial palsy. Treatment consists of prednisone 60-80 mg per day for one week. In addition, eye care in patients with BP must be a priority. The prognosis of BP is excellent, with 85% of patients regaining function within three weeks.